Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-18

FDA Approved: SOFDRA — Original Application (Botanix SB Inc.)

View source ↗

Summary

The FDA approved SOFDRA (sofpironium bromide) from Botanix SB Inc. through an original NDA for the treatment of primary axillary hyperhidrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SOFDRA (SOFPIRONIUM BROMIDE)

Snippet

ORIG AP for SOFDRA (SOFPIRONIUM BROMIDE)